IL6 and COVID-19: Giamarellos-Bourboulis et al. [14] reported that immune dysregulation in cases of severe COVID-19 was mainly characterized by low expression of IL-6-mediated human leukocyte antigen D-related (HLA-DR) and a decrease in lymphocytes and NK cells.